Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients ≥65 years of age (The Italian longitudinal study on aging)

被引:33
|
作者
Solfrizzi, V
Panza, F
Colacicco, AM
Capurso, C
D'Introno, A
Torres, F
Baldassarre, G
Capurso, A
机构
[1] Univ Bari Policlin, Ctr Lipoprotein Metab, Dept Geriatr, I-70124 Bari, Italy
[2] Miulli Reg Hosp, Div Geriatr, Bari, Italy
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 89卷 / 07期
关键词
D O I
10.1016/S0002-9149(02)02192-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High levels of serum lipoprotein(a) [Lp(a)] have been associated with increased risk of coronary artery disease (CAD), but this association apparently is not confirmed in elderly people. We evaluated the interactions of Lp(a) with lipid and nonlipid CAD risk factors in a sample of subjects enrolled in the prevalence survey (1992 to 1993) of the Italian Longitudinal Study on Aging (ILSA). The entire population consisted of 5,632 elderly people, aged 65 to 84 years, randomly selected in 8 Italian municipalities. The present cross-sectional study included 400 free-living elderly subjects (74 +/- 6 years) from the randomized cohort of Casamossima (Bari, Southern Italy) (n = 704). The results showed that in the elderly population, high serum Lp(a) is a CAD risk factor dependent on type 2 diabetes mellitus and elevoted low-density lipoprotein (LDL) cholesterol levels. In particular, the combined effect of high Lp(a) (greater than or equal to20 mg/ dl) and high LDL cholesterol (greater than or equal to3.63 mmol/L [greater than or equal to140 mg/dl]), increases coronary risk by 2.75 (95% confidence interval 7.70 to 0.99); finally, the effect of Lp(a) greater than or equal to20 mg/dl and LDL cholesterol greater than or equal to3.63 mmol/L (greater than or equal to140 mg/dl), combined with type 2 diabetes mellitus, increases risk of CAD by 6.65 (95% confidence interval 35.40 to 1.25). In the elderly, elevated Lp(a) levels appear not to be an independent predictor of CAD, but this lipoprotein is a risk factor only in subjects with type 2 diabetes mellitus and elevated LDL cholesterol. (C) 2002 by Excerpta Medica, Inc.
引用
收藏
页码:825 / 829
页数:5
相关论文
共 50 条
  • [1] Atorvastatin and Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus Patients on Hemodialysis
    Maerz, Winfried
    Genser, Bernd
    Drechsler, Christiane
    Krane, Vera
    Grammer, Tanja B.
    Ritz, Eberhard
    Stojakovic, Tatjana
    Scharnagl, Hubert
    Winkler, Karl
    Holme, Ingar
    Holdaas, Hallvard
    Wanner, Christoph
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06): : 1316 - 1325
  • [2] Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
    Bays, Harold E.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2014, 7 : 355 - 364
  • [3] Low-density lipoprotein cholesterol predicts coronary artery calcification events in patients with type 2 diabetes: a longitudinal study
    Zou, Zhi
    Sun, Yongbing
    Zou, Lijun
    Zhou, Yang
    Lin, Xinbei
    Zhou, Jing
    Li, Zhonglin
    Wu, Xiaoling
    Wang, Ling
    Li, Xiaodong
    Wang, Yong
    Hu, Yangxi
    Li, Fengli
    Zhang, Jiancheng
    Li, Yongli
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [4] Comparative effects of statins on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in patients ≥65 years of age.
    Bays, HE
    Deedwania, PC
    Jones, PH
    Caplan, RJ
    Blasetto, JW
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S126 - S126
  • [5] Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan diabetes prevention study
    Janghorbani, Mohsen
    Soltanian, Nouralddin
    Amini, Masoud
    Aminorroaya, Ashraf
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (05) : 715 - 719
  • [6] Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl
    Cromwell, William C.
    Otvos, James D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (12): : 1599 - 1602
  • [7] GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Hsu, Wei-Hao
    Lai, Chia-Wei
    Chen, Szu-Chia
    Chiou, Hsin-Ying Clair
    Hsiao, Pi-Jung
    Shin, Shyi-Jang
    Lee, Mei-Yueh
    ENDOCRINE PRACTICE, 2019, 25 (09) : 918 - 925
  • [8] Comparison of existing methods of low-density lipoprotein cholesterol estimation in patients with type 2 diabetes mellitus
    Sng, Gerald Gui Ren
    Khoo, You Liang
    Yeo, Khung Keong
    Loh, Wann Jia
    Aw, Tar Choon
    Khoo, Joan Joo Ching
    Lee, Lynette Mei Yi
    Tan, Gilbert Choon Seng
    Tan, Hong Chang
    Bee, Yong Mong
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (06) : 280 - 288
  • [9] Autoantibodies to oxidized low-density lipoprotein in patients with Type 2 diabetes mellitus
    Hsu, RM
    Devaraj, S
    Jialal, I
    CLINICA CHIMICA ACTA, 2002, 317 (1-2) : 145 - 150
  • [10] Very low-density lipoprotein cholesterol is associated with extent and severity of coronary artery disease in patients with type 2 diabetes mellitus
    Jia, Aimei
    Zeng, Wei
    Yu, Liuqin
    Zeng, Huirun
    Lu, Zhan
    Song, Yongyan
    SAGE OPEN MEDICINE, 2019, 7